Ушбу ишга иқтибос қилган ишлар

4 та иш

Иш: Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

1. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

   S.K. Abidi, Jay Achar, M.M. Assao Neino +34

   МақолаTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 иқтибос

   ABIABI:AkademIndex/openalex/2019.article.000020

2. Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis

   Aleksandr Trubnikov, Arax Hovhannesyan, Kristina Akopyan +5

   МақолаTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.262608

3. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

   Philipp du Cros, Atadjan Khamraev, Zinaida Tigay +15

   МақолаTuberculosis Research and EpidemiologyERJ Open Research20201 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.360284

4. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

   Shona Horter, Jay Achar, Nell Gray +4

   МақолаTuberculosis Research and EpidemiologyPLoS ONE20201 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.360285